Latest Genetic testing Stories

Fertility Centers of Illinois discusses genetic screening for breast cancer and fertility preservation during a breast cancer diagnosis. Chicago, IL (PRWEB) May 17, 2013 After learning she had an 87 percent risk of breast cancer due to a genetic predisposition through the BRCA1 gene, Angelina Jolie made the decision to undergo a [preventative double mastectomy, lessening her risk to five percent. Angelina’s decision shines the spotlight on genetic predisposition to disease, and what...

NEW YORK, May 17, 2013 /PRNewswire/ -- Sudler & Hennessey, one of the leading global healthcare communication agencies, announces an agreement between Sudler's eHealth Group and NextGxDx, an online genetic testing marketplace for healthcare providers and hospitals. Emerging trends in healthcare focus on cost, quality, and access to care and information. As personalized medicine continues to expand, and as new genetic tests are introduced daily, integration of these tests into...

Actress Angelina Jolie’s decision to undergo preventive surgery for breast cancer has sparked a frenzy of discussion regarding BRCA gene testing and the increasingly common preventive mastectomy. Did she make the right choice, and how young is “too young” to consider taking drastic action to avoid breast cancer? Beverly Hills, CA (PRWEB) May 16, 2013 The rate of women opting to undergo preventive mastectomies to avoid the risk of breast cancer has increased as much as 50 percent in...

KANSAS CITY, Kan., May 14, 2013 /PRNewswire/ -- Actress Angelina Jolie has sparked a national conversation after opting to undergo a preventative double mastectomy after testing positive for the breast cancer gene. Jolie's family history combined with her test results put her at high risk for breast and ovarian cancer according to news reports. "Personal and family history are the major determinants for genetic testing," said Jennifer Klemp, Ph.D, MPH, director, Breast Cancer...

Comprehensive menu provides crucial information about inherited cardiovascular testing to individuals and families IRVINE, Calif., May 8, 2013 /PRNewswire/ -- Aviir Inc., a biotechnology company dedicated to the prevention of cardiovascular disease through innovative laboratory tests, announced that it will be extending its offered services with comprehensive inherited cardiovascular disease genetic test menu. (Logo: http://photos.prnewswire.com/prnh/20130319/LA79677LOGO) The...

Researchers at Mayo Clinic in Florida participated in a nationwide study that found minor differences between genes that contribute to late-onset Alzheimer's disease in African-Americans and in Caucasians. The study, published April 10 in The Journal of the American Medical Association, was the first to look at the genetics of a large number of African-Americans diagnosed with this common form of Alzheimer's disease (1,968 patients) compared to 3,928 normal elderly African-American control...

Genetic study of late-onset Alzheimer disease in African Americans identifies unique risk levels A variation in the gene ABCA7 causes a twofold increase in the risk of late onset Alzheimer disease among African Americans, according to a meta-analysis by a team of researchers including experts from the Perelman School of Medicine at the University of Pennsylvania. This is the largest analysis to date to determine genetic risk associated with late-onset Alzheimer disease (LOAD) specifically...

Individualized Genomic Testing Allows for Tailored Cancer Treatment, New Drug Research PHILADELPHIA, April 6, 2013 /PRNewswire-USNewswire/ -- Just like a massive iceberg jutting out of the ocean, many of cancer's genetic underpinnings remain hidden under the surface, impossible to predict or map from above. The foreboding shadows and shapes that appear on CT scans and MRIs - and even in the field that doctors see when they zoom in to look at cancer cells under a high-powered...

Tool lets any clinician contribute information about patients for analysis A new online database combining symptoms, family history and genetic sequencing information is speeding the search for diseases caused by a single rogue gene. As described in an article in the May issue of Human Mutation, the database, known as PhenoDB, enables any clinician to document cases of unusual genetic diseases for analysis by researchers at the Johns Hopkins University School of Medicine or the Baylor...

Eligible API's Connections to more than 700 Payers to Deliver Real-Time Coverage Information NASHVILLE, Tenn., March 18, 2013 /PRNewswire/ -- NextGxDx Inc., which provides an online genetic testing marketplace for healthcare professionals and hospitals, today announced that they will be leveraging Eligible API to connect their users to real-time eligibility and benefit information from the vast majority of U.S. healthcare payers. By integrating Eligible into the NextGxDx platform,...